|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 95 JPY | -2.06% |
|
+5.56% | -12.04% |
Ribomic Inc. provided non-consolidated earnings guidance for the full year ending March 31, 2022. For the period, the company expects operating revenue to be JPY 65 million. Operating loss is expected to be JPY 2,402 million.
Loss is expected to be JPY 2,294 million. Loss per share is expected to be JPY 80.35.
| 1st Jan change | Capi. | |
|---|---|---|
| -12.04% | 22.43M | |
| +16.26% | 122B | |
| +19.60% | 113B | |
| +3.17% | 22.66B | |
| -17.11% | 21.34B | |
| -39.57% | 16.92B | |
| -14.20% | 16.68B | |
| -16.26% | 16.61B | |
| +3.09% | 13.62B | |
| +21.70% | 11.04B |
RIBOMIC INC. 
